Who owns Elevation Oncology Inc?
- Ticker: ELEV
- CUSIP Number: 28623u101
Tip: Access positions for across all investors
Analyze quarterly positions in Elevation Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Elevation Oncology stock
Who bought or sold Elevation Oncology Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Farallon Capital Management | 3.9M | $20M | 100% | Mar 2024 |
|
Point72 Asset Management | 3.4M | $17M | 100% | Mar 2024 |
|
Tang Capital Management | 3.1M | $16M | -17% | Mar 2024 |
|
Balyasny Asset Management | 3.1M | $16M | 100% | Mar 2024 |
|
Aisling Capital Management | 2.8M | $1.5M | 0% | Dec 2023 |
|
venBio Partners | 2.7M | $14M | -7% | Mar 2024 |
|
Braidwell | 2.4M | $12M | 100% | Mar 2024 |
|
Qiming U.S. Ventures Management | 2.4M | $1.3M | 0% | Dec 2023 |
|
Darwin Global Management | 2.3M | $12M | 100% | Mar 2024 |
|
BVF | 2.3M | $12M | 0% | Mar 2024 |
|
Citadel Advisors | 1.6M | $8.1M | 165% | Mar 2024 |
|
Vanguard Group | 1.5M | $7.9M | 31% | Mar 2024 |
|
Artal Group | 1.5M | $7.8M | 100% | Mar 2024 |
|
Hudson Bay Capital Management | 1.5M | $7.8M | 177% | Mar 2024 |
|
Palo Alto Investors | 1.3M | $6.9M | 100% | Mar 2024 |
|
Logos Global Management | 1.0M | $5.1M | 100% | Mar 2024 |
|
OrbiMed Advisors | 941k | $4.8M | -37% | Mar 2024 |
|
Laurion Capital Management | 889k | $4.6M | 100% | Mar 2024 |
|
Walleye Trading Advisors | 787k | $4.0M | 100% | Mar 2024 |
|
Millennium Management | 669k | $3.4M | -78% | Mar 2024 |
|
Goldman Sachs Group | 551k | $2.8M | 100% | Mar 2024 |
|
Velan Capital Investment Management | 497k | $2.6M | 0% | Mar 2024 |
|
Sphera Funds Management | 430k | $2.2M | -52% | Mar 2024 |
|
Exome Asset Management | 369k | $1.9M | 100% | Mar 2024 |
|
Geode Capital Management | 348k | $1.8M | 51% | Mar 2024 |
|
Bank of America Corporation | 245k | $1.3M | 59% | Mar 2024 |
|
Schonfeld Strategic Advisors | 176k | $905k | 1151% | Mar 2024 |
|
BlackRock | 172k | $882k | 359% | Mar 2024 |
|
Ikarian Capital | 148k | $760k | -87% | Mar 2024 |
|
Qube Research & Technologies | 143k | $732k | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 137k | $704k | 56833% | Mar 2024 |
|
Hrt Financial | 133k | $683k | 100% | Mar 2024 |
|
Marshall Wace | 133k | $681k | 100% | Mar 2024 |
|
UBS Group | 123k | $629k | -5% | Mar 2024 |
|
Man Group | 121k | $622k | 100% | Mar 2024 |
|
Citigroup | 120k | $613k | 100% | Mar 2024 |
|
Bridgeway Capital Management | 107k | $546k | 88% | Mar 2024 |
|
Springbok Capital Management | 100k | $515k | 100% | Mar 2024 |
|
Jane Street | 79k | $405k | 100% | Mar 2024 |
|
Squarepoint Ops | 69k | $356k | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 68k | $351k | 100% | Mar 2024 |
|
Northern Trust | 65k | $332k | 46% | Mar 2024 |
|
Polar Securities | 55k | $281k | 100% | Mar 2024 |
|
Annandale Capital | 50k | $27k | 0% | Dec 2023 |
|
Boothbay Fund Management | 39k | $202k | -85% | Mar 2024 |
|
American Century Companies | 32k | $162k | 100% | Mar 2024 |
|
Brevan Howard Capital Management | 28k | $146k | 100% | Mar 2024 |
|
Morgan Stanley | 28k | $144k | 719% | Mar 2024 |
|
Bank Of Montreal | 23k | $116k | 100% | Mar 2024 |
|
Y-Intercept | 22k | $112k | 100% | Mar 2024 |
|
Ameriprise Financial | 20k | $104k | 100% | Mar 2024 |
|
Leucadia National Corporation | 18k | $94k | 100% | Mar 2024 |
|
Palumbo Wealth Management | 18k | $91k | 100% | Mar 2024 |
|
Cambridge Investment Research Advisors | 16k | $83k | 100% | Mar 2024 |
|
SG Americas Securities | 12k | $63k | 100% | Mar 2024 |
|
CTC Alternative Strategies | 11k | $57k | 100% | Mar 2024 |
|
ADAR1 Capital Management | 8.6k | $44k | 100% | Mar 2024 |
|
Advisor Group Holdings | 3.0k | $15k | 50% | Mar 2024 |
|
Wells Fargo & Company | 245.00 | $1.3k | 2% | Mar 2024 |
|
Tower Research Capital | 23.00 | $117.999200 | -100% | Mar 2024 |
|
Who sold out of Elevation Oncology?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
ExodusPoint Capital Management | Sep 2023 | 1000k | $662k |
Armistice Capital | Sep 2023 | 750k | $497k |
DAFNA Capital Management | Dec 2023 | 450k | $242k |
Two Sigma Investments | Dec 2023 | 365k | $196k |
Two Sigma Advisers | Dec 2023 | 103k | $55k |
Royal Bank of Canada | Dec 2023 | 370.00 | $0 |